9-ING-41 in Patients With Advanced Cancers
Actuate Therapeutics Inc.
Actuate Therapeutics Inc.
Fluidx Medical Technology, Inc.
M.D. Anderson Cancer Center
University of Southern California
M.D. Anderson Cancer Center
UNC Lineberger Comprehensive Cancer Center
The University of Texas Health Science Center at San Antonio
Washington University School of Medicine
Tempus AI